Algernon Pharmaceuticals Inc says NeuroScience unit doses fi

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that its subsidiary, Algernon NeuroScience (AGN Neuro), has dosed the first subject in...

Related Keywords

Canada , Netherlands , London , City Of , United Kingdom , Canadian , Edmundj Safra , David Nutt , Christopher Moreau , Rick Strassman , Imperial College London , Constraint Induced Movement Therapy , Algernon Pharmaceuticals , Division Of Brain Science , Department Of Medicine , Algernon Pharmaceuticals Inc , Centre For Human Drug Research In Leiden , Algernon Neuroscience , Human Drug Research , Brain Derived Neurotrophic Factor , Spirit Molecule , Brain Science , Hammersmith Hospital , Constraint Induced Movement ,